Trial Profile
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2012
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Male osteoporosis
- Focus Therapeutic Use
- 04 May 2012 New trial record